Back to search

Aristotle University Of Thessaloniki (AUTH)

Η επίδραση της φυσικής ανοσίας και νεότερων αντιμυκητιακών παραγόντων στα βιολογικά υμένια από στελέχη candida

Abstract

dc:description

Introduction: Biofilm formation is an important component of catheter-related infections and generally infections related to indwelling medical devices. It is estimated that 65% of all human infections are caused by organisms growing in biofilms. Although the majority of these infections are caused by bacteria, fungal infections are becoming increasingly common; especially those caused by Candida spp., most notably Candida albicans. In children, as in adults, C. albicans ranks as the third most common cause of nosocomial bloodstream infections. In neonates, Candida parapsilosis is of particular concern given this organism’s high prevalence in catheter-related infections. Even with current antifungal therapy, mortality of patients with invasive candidiasis can be as high as 40%. Biofilms are increasingly recognized as important health problems because they are much more resistant to both antibiotics and host defence mechanisms than their planktonic counterparts. Objectives: To determine the in vitro activities of the newer antifungal agents voriconazole (VRC), posaconazole (PSC), caspofungin (CAS) and anidulafungin (ANID) against C. albicans and C. parapsilosis biofilms. Additionally, to determine the effect of human phagocytes (polymorphonuclear leukocytes, PMNs and monocytes, MNCs) alone and in combination with antifungal agents against C. albicans and C. parapsilosis biofilms. Materials-Methods: Biofilms were grown in vitro by incubation of Candida clinical isolates on the surface of silicone elastomer disks placed in 12-well or 96-well culture plates at 37°C under constant shaking for 48 h and 72 h for C. albicans and C. parapsilosis, respectively. Mature biofilms were then incubated with two-fold dilutions of VRC (0.12-256 mg/L), PSC (0.06-64 mg/L), CAS (0.01-16 mg/L) or ANID (0.007- 16 mg/L) for 24h. Percent biofilm damage was then assessed colorimetrically by XTT assay as reduction in the metabolic activity of biofilms. Biofilm MIC (BF-MIC) was defined as the least antifungal concentration causing ≥50% reduction in the metabolic activity of biofilm compared to controls. Planktonic MIC (PL-MIC) was determined according to CLSI M27-A2 microdilution method. In host defense experiments, mature biofilms were incubated with PMNs or MNCs at various dilutions. Phagocytic challenge by Candida cells was determined through the production of hydrogen peroxide (H₂O₂) and H₂O₂-dependent intracellular intermediates by means of flow cytometry. The combined effect of antifungal agents with human phagocytes was determined after incubation of PMNs or MNCs with VRC, PSC, CAS or ANID for 22 h at selected dilutions. Percent fungal damage was assessed by means of XTT assay and the morphological changes of biofilms were visualized by confocal microscopy. Cytokine release was measured by ELISA. Identical conditions were carried out with planktonic counterparts. Results: C. albicans biofilms were susceptible to echinocandins (CAS and ANID) having comparable MICs with their planktonic counterparts. C. parapsilosis biofilms had BF-MIC for echinocandins higher than PL-MIC, however BF-MIC were within the clinically achievable range of concentrations. On the contrary, biofilms were >1000 more resistant to azoles (VRC and PSC) compared with their planktonic counterparts. None of the antifungal agents tested achieved complete sterility of the silicone substrate from Candida biofilms. Biofilms appeared more resistant to phagocytes than planktonic cells. Similar phenomenon was not observed for resuspended biofilm cells. Resuspended biofilm cells and planktonic cells induced the same fungal damage and oxidative burst by human phagocytes. Confocal microscopy demonstrated absence of phagocytosis within biofilms. Preincubation of phagocytes with cytokines (IFN-γ or G-CSF) did not augment phagocytic effect against biofilms. Besides, biofilms were more resistant to the combined effect of phagocytes and antifungal agents as compared with their planktonic counterparts. An additive effect occurred between phagocytes and ANID against C. albicans and C. parapsilosis biofilms. ANID elicited an increased TNF-a and a reduced IL-8 release from MNCs incubated with C. albicans biofilms. The immunopharmocological effects of antifungal agents against biofilms correlated with changes in biofilm morphology, as depicted by confocal microscopy. Conclusions: Echinocandins are more effective than azoles against Candida spp. biofilms. Biofilm resistance to host defenses could be attributed to lack of phagocytosis. The additive interaction of ANID with phagocytes against Candida biofilms results in a beneficial Th1 response. This finding could open up new avenues for the management of infections related to Candida biofilms. Together our observations suggest that the major contributor for this recalcitrant behaviour of Candida biofilms could be the biofilm ultrastructure.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2010

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Katragkou, Aspasia
  • Κατράγκου, Ασπασία

Subjects

dc:subject × 20

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/20079

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Katragkou, Aspasia; Κατράγκου, Ασπασία. Η επίδραση της φυσικής ανοσίας και νεότερων αντιμυκητιακών παραγόντων στα βιολογικά υμένια από στελέχη candida. Aristotle University Of Thessaloniki (AUTH), 2010. http://hdl.handle.net/10442/hedi/20079